Clinical Commander

Back to dossier
ent.peritonsillar-abscess.core.v1PRODUCTION
ent.peritonsillar-abscess.core.v1

Peritonsillar abscess (quinsy)

general_internal_medicineacutesubacuteadultpediatric
Hard-required inputs
0 / 9
Care setting:

Encounter flow

12/12 authored

Canonical 12-phase frame with authored status for this dossier.

Current phase

Frame

Detailed

Frame as the peritonsillar cellulitis → abscess continuum: severe unilateral sore throat + trismus + muffled voice + uvular deviation. Distinguish from symmetric pharyngitis/tonsillitis, infectious mononucleosis, epiglottitis, retropharyngeal abscess, and odontogenic deep-space infection. Airway, deep-space surgical source control, sepsis, and EBV-mono pathways are routed OUT, not authored here.

Inputs
0
Actions
0
Advance rule
Set
Advance when

PTA scope confirmed; airway/deep-space/sepsis/mono concerns flagged for routing by engine_id

Patient inputs (15)

Trismus from medial-pterygoid irritation is a key abscess discriminator vs simple tonsillitis and worsens drainage access (Klug Dan Med J 2017)

Uvular deviation away from the lesion + soft-palate fullness raises the abscess (vs cellulitis) post-test probability (Kim Acad Emerg Med 2023)

Muffled "hot-potato" voice localises a supratonsillar/oropharyngeal mass; stridor/quiet voice instead pivots toward epiglottitis (Klug Dan Med J 2017)

Fever supports a suppurative process and severity class; high fever + rigors raises the bacteraemia/Lemierre concern (Klug Dan Med J 2017)

Unilateral, asymmetric throat pain with referred otalgia favours peritonsillar abscess over symmetric pharyngitis/tonsillitis (Kim Acad Emerg Med 2023 — clinical exam ~75% sensitive)

Stridor, tripod posture, air hunger, severe drooling with cyanosis → airway emergency; recognise then route to ent.epiglottitis.core.v1 (Klug Dan Med J 2017 — airway obstruction is a PTA complication)

Lateral neck swelling, torticollis, or trismus out of proportion suggests parapharyngeal/retropharyngeal spread → route to ent.retropharyngeal-abscess.core.v1 (Hu Medicina 2022 — mediastinitis precursor)

Hypotension with a deep-neck source → systemic toxicity; recognise then route to id.sepsis.core.v1 (SSC — sepsis pathway not authored here)

Severe penicillin allergy switches first-line β-lactam/β-lactamase-inhibitor to clindamycin (anaerobe + GAS cover) (Klug Dan Med J 2017 — clindamycin preferred over macrolide given Fusobacterium)

Intraoral/transcervical POCUS (or contrast CT if POCUS equivocal or deep-space spread suspected) resolves the cellulitis-vs-abscess question and guides aspiration (Kim Acad Emerg Med 2023 — pooled US sens 86% / spec 76%)

Diabetes / immunosuppression broadens pathogen spectrum, lowers drainage/CT and admission threshold, and raises complication risk (Gawel Int Arch Otorhinolaryngol 2025 — PTA tonsillectomy patients have higher diabetes/sepsis rates)

Leukocytosis supports a suppurative process and feeds the severity / mediastinitis-risk chain (Hu Medicina 2022)

Very high CRP (e.g. >190-340 mg/L) is associated with descending mediastinitis risk in deep-neck infection (Hu Medicina 2022)

Anticoagulation / bleeding diathesis changes the drainage risk-benefit (post-procedure bleeding) and may favour aspiration over incision (Chang Cochrane 2016)

Antibiotic-safety gating for the regimen (penicillin-class/clindamycin preferred; metronidazole considerations) (WebSearch guideline review 2026-05-17)

* = hard-required. Engine cannot meaningfully run until these are filled.

Severity triggers (8)

8 need judgement
  • informationallife_threateningairway_obstruction_route_out
    Stridor, tripod posture, air hunger, severe drooling with cyanosis, or rapidly deteriorating airway with trismus + muffled voice (Klug Dan Med J 2017 — airway obstruction is a PTA complication)
    Trigger could not be auto-evaluated — needs clinician judgement.
  • informationallife_threateningdescending_necrotizing_mediastinitis
    Very high / rapidly rising CRP (e.g. >190-340 mg/L), chest or back pain, dyspnoea, or anterior-visceral/retropharyngeal space involvement on CT (Hu Medicina 2022 — mortality up to 85% if untreated)
    Trigger could not be auto-evaluated — needs clinician judgement.
  • informationallife_threateninglemierre_syndrome
    Rigors, pleuritic chest pain, neck-vein tenderness, septic pulmonary emboli, or persistent bacteraemia after an oropharyngeal infection — Fusobacterium necrophorum internal-jugular thrombophlebitis (Wright South Med J 2012; Tiwari Cureus 2023)
    Trigger could not be auto-evaluated — needs clinician judgement.
  • informationalsevereparapharyngeal_retropharyngeal_spread
    Lateral/posterior neck swelling, torticollis, neck stiffness, trismus out of proportion, or posterior pharyngeal bulge — deep-space extension beyond the peritonsillar space (Klug Dan Med J 2017 — ~52% PPA had concomitant PTA)
    Trigger could not be auto-evaluated — needs clinician judgement.
  • informationalseveresystemic_toxicity_route_to_sepsis
    qSOFA ≥2, hypotension on adequate fluids, or NEWS2/SIRS-positive systemic toxicity with the deep-neck source (SSC; Rosi-Schumacher 2023 — ~51% pediatric PTA met SIRS/sepsis)
    Trigger could not be auto-evaluated — needs clinician judgement.
  • informationalmoderateimmunocompromised_high_risk
    Diabetes, immunosuppression, or transplant with PTA — broader pathogen spectrum, higher complication and sepsis risk, lower drainage/CT and admission threshold (Gawel Int Arch Otorhinolaryngol 2025 — PTA tonsillectomy patients had higher diabetes/sepsis rates)
    Trigger could not be auto-evaluated — needs clinician judgement.
  • informationalmoderatefailed_bedside_drainage_or_trismus_access
    Severe trismus precluding bedside drainage, failed/incomplete needle aspiration with persistent collection, or re-accumulation at 24-48 h (Mansour Eur Arch Otorhinolaryngol 2019 — aspiration repeat rate ~46%)
    Trigger could not be auto-evaluated — needs clinician judgement.
  • informationalmildrecurrent_pta_tonsillectomy_candidacy
    ≥1 prior peritonsillar abscess or recurrent tonsillitis meeting AAO-HNS modifying-factor criteria (AAO-HNS Tonsillectomy 2019 — >1 PTA is a tonsillectomy modifying factor)
    Trigger could not be auto-evaluated — needs clinician judgement.

Workflow calculators

Run this disease's risk and dosing calculators inline.

ENTRYoptionalDrives risk stratification
Loading…

Recommended regimen

Peritonsillar abscess — drainage ladder + anaerobe/GAS antimicrobial + adjunct steroid
axis: pta_drainage_antimicrobial_adjunctstep 1 - Step 1 — Source control: drain the confirmed abscess
Selected step "Step 1 — Source control: drain the confirmed abscess" — Drainable collection confirmed on POCUS/CT (or strong clinical gestalt with classic uvular deviation + fluctuant bulge); peritonsillar cellulitis WITHOUT a collection → skip drainage, treat medically + observe
  • needle_aspiration
    first line
    source_control_procedure
    triggers: drainable_collection, cooperative_patient, aspiration_preferred_for_pain, anticoagulated_bleeding_risk
    Chang Cochrane 2016 (PMID 28009937) — needle aspiration is less painful than I&D; very-low-quality evidence suggests higher recurrence (RR 3.74, 95% CI 1.63-8.59 favouring I&D); often POCUS-guided (Todsen Diagnostics 2018, PMID 30072648)
  • incision_and_drainage
    first line
    source_control_procedure
    triggers: drainable_collection, lower_recurrence_preferred, loculated_or_large_abscess
    Chang Cochrane 2016 (PMID 28009937) — I&D associated with lower recurrence than aspiration (RR 3.74); Mansour Eur Arch Otorhinolaryngol 2019 (PMID 31300842) — shorter LOS + fewer repeat procedures vs aspiration; post-I&D bleeding ~3.6%
  • quinsy_acute_tonsillectomy
    second line
    source_control_procedure
    triggers: recurrent_pta, failed_bedside_drainage, concurrent_tonsillectomy_indication, trismus_precludes_bedside_drainage, pediatric_general_anaesthesia
    Rosi-Schumacher Int J Pediatr Otorhinolaryngol 2023 (PMID 37352593) — quinsy tonsillectomy and I&D have equivalent outcomes; Gawel Int Arch Otorhinolaryngol 2025 (PMID 41113746) — quinsy tonsillectomy safe (no excess haemorrhage) despite higher comorbidity

ed playbook — drug actions (4)

  1. 1. needle aspiration OR incision-and-drainage of confirmed abscess
    procedure (POCUS-guided where available) • intraoral • once; repeat/escalate if re-accumulation
    trigger: Drainable collection on POCUS/CT or classic fluctuant bulge (Chang Cochrane 2016)
    Source control is primary; aspiration less painful, I&D lower recurrence (RR 3.74)
  2. 2. ampicillin-sulbactam IV (or amoxicillin-clavulanate PO if dischargeable)
    rxcui 1009148
    3 g IV / 875-125 mg PO • IV/PO • q6h IV / BID PO
    trigger: All PTA + peritonsillar cellulitis (Klug Dan Med J 2017)
    GAS + anaerobe (incl. Fusobacterium) cover
  3. 3. clindamycin (penicillin anaphylaxis)
    rxcui 2582
    600 mg IV / 300-450 mg PO • IV/PO • q8h / QID
    trigger: Severe penicillin allergy (Klug Dan Med J 2017)
    Fusobacterium-aware β-lactam alternative; C. difficile counsel
  4. 4. dexamethasone (single dose, adjunct)
    rxcui 3264
    10 mg adult / 0.15-0.6 mg/kg paeds • IV • single dose
    trigger: Post-drainage / severe trismus-pain / cellulitis (Hur Laryngoscope 2018)
    Faster fever/pain/intake recovery; no adverse events in pooled RCTs

Auto-drafted A&P note

ed

Subjective

- Possible entry pathways: Severe unilateral sore throat with trismus, dysphagia, and odynophagia worsening over 2-5 days (classic peritonsillar abscess presentation — Klug Dan Med J 2017; Kim Acad Emerg Med 2023); "Hot-potato"/muffled voice with uvular deviation, soft-palate fullness, and contralateral tonsillar displacement (cardinal abscess sign — Chang Cochrane 2016); Drooling / pooled secretions with trismus and inability to tolerate oral secretions — airway + dehydration entry (Klug Dan Med J 2017).

Objective

- No vitals, labs, or imaging entered for this encounter.

Assessment

**Peritonsillar abscess (quinsy)** (ent.peritonsillar-abscess.core.v1).
Phenotype framing: Terminal differential with pivot findings: peritonsillar abscess vs peritonsillar cellulitis (drainable collection on POCUS/CT pivot) vs severe tonsillitis/pharyngitis (symmetric, no uvular deviation, no trismus pivot) vs infectious mononucleosis (bilateral exudate + posterior cervical nodes + splenomegaly + atypical lymphocytes pivot — route to ent.pharyngitis.core.v1) vs epiglottitis (rapid airway, stridor, minimal oral findings, "thumbprint" pivot — route to ent.epiglottitis.core.v1) vs retropharyngeal abscess (neck stiffness, posterior pharyngeal bulge, CT pivot — route to ent.retropharyngeal-abscess.core.v1) vs odontogenic/dental deep-space infection (molar source, floor-of-mouth pivot).
Scope: Frame as the peritonsillar cellulitis → abscess continuum: severe unilateral sore throat + trismus + muffled voice + uvular deviation. Distinguish from symmetric pharyngitis/tonsillitis, infectious mononucleosis, epiglottitis, retropharyngeal abscess, and odontogenic deep-space infection. Airway, deep-space surgical source control, sepsis, and EBV-mono pathways are routed OUT, not authored here.

No severity triggers fired against current inputs.

Plan

Regimen axis: **Peritonsillar abscess — drainage ladder + anaerobe/GAS antimicrobial + adjunct steroid** — step "Step 1 — Source control: drain the confirmed abscess".
1. needle_aspiration (source_control_procedure, first line) — Chang Cochrane 2016 (PMID 28009937) — needle aspiration is less painful than I&D; very-low-quality evidence suggests higher recurrence (RR 3.74, 95% CI 1.63-8.59 favouring I&D); often POCUS-guided (Todsen Diagnostics 2018, PMID 30072648)
2. incision_and_drainage (source_control_procedure, first line) — Chang Cochrane 2016 (PMID 28009937) — I&D associated with lower recurrence than aspiration (RR 3.74); Mansour Eur Arch Otorhinolaryngol 2019 (PMID 31300842) — shorter LOS + fewer repeat procedures vs aspiration; post-I&D bleeding ~3.6%
3. quinsy_acute_tonsillectomy (source_control_procedure, second line) — Rosi-Schumacher Int J Pediatr Otorhinolaryngol 2023 (PMID 37352593) — quinsy tonsillectomy and I&D have equivalent outcomes; Gawel Int Arch Otorhinolaryngol 2025 (PMID 41113746) — quinsy tonsillectomy safe (no excess haemorrhage) despite higher comorbidity

Setting playbook (ed) — Resolve cellulitis-vs-abscess (POCUS/CT), screen + route the dangerous extensions, drain a confirmed abscess at the bedside, start anaerobe/GAS antibiotic + adjunct steroid, decide admit vs discharge (Kim Acad Emerg Med 2023; Chang Cochrane 2016; Hur Laryngoscope 2018)
4. needle aspiration OR incision-and-drainage of confirmed abscess procedure (POCUS-guided where available) intraoral once; repeat/escalate if re-accumulation — Drainable collection on POCUS/CT or classic fluctuant bulge (Chang Cochrane 2016) (Source control is primary; aspiration less painful, I&D lower recurrence (RR 3.74))
5. ampicillin-sulbactam IV (or amoxicillin-clavulanate PO if dischargeable) 3 g IV / 875-125 mg PO IV/PO q6h IV / BID PO — All PTA + peritonsillar cellulitis (Klug Dan Med J 2017) (GAS + anaerobe (incl. Fusobacterium) cover)
6. clindamycin (penicillin anaphylaxis) 600 mg IV / 300-450 mg PO IV/PO q8h / QID — Severe penicillin allergy (Klug Dan Med J 2017) (Fusobacterium-aware β-lactam alternative; C. difficile counsel)
7. dexamethasone (single dose, adjunct) 10 mg adult / 0.15-0.6 mg/kg paeds IV single dose — Post-drainage / severe trismus-pain / cellulitis (Hur Laryngoscope 2018) (Faster fever/pain/intake recovery; no adverse events in pooled RCTs)

Non-pharmacologic actions:
- IV fluids for drooling/odynophagia-related dehydration (Klug Dan Med J 2017)
- Multimodal analgesia; topical anaesthetic to enable bedside drainage
- ENT consultation for trismus precluding bedside drainage, recurrent PTA, or OR/quinsy candidacy (Rosi-Schumacher 2023)
- Send aspirate for culture incl. anaerobic/Fusobacterium media at drainage (Klug Dan Med J 2017)

AVOID / contraindication checks:
- Penicillin anaphylaxis block ampicillinsulbactam amoxclav penicillinG (use clindamycin ± metronidazole — Klug Dan Med J 2017)
- Clindamycin c diff counsel (lincosamide C. difficile risk)
- Metronidazole alcohol disulfiram reaction counsel
- Anticoagulation or bleeding diathesis favours aspiration over incision (Chang Cochrane 2016 — weigh post procedure bleeding)
- Pregnancy prefer penicillin class or clindamycin (review metronidazole risk benefit; WebSearch guideline review 2026 05 17)
- Do not delay airway or surgical source control for antibiotics (Klug Dan Med J 2017 — drainage is primary)

Monitoring

Regimen monitoring:
- symptomatic improvement expected within 24-48h of drainage (Klug Dan Med J 2017)
- persistent fever or trismus at 24-48h reimage for reaccumulation or deep space spread (Hu Medicina 2022)
- post drainage bleeding watch (Chang Cochrane 2016 — post-I&D ~3.6%)
- delayed Lemierre watch rigors pleuritic chest pain neck vein tenderness (Wright South Med J 2012)
- renal dose recheck for betalactam and metronidazole (Inker NEJM 2021)

Setting (ed) monitoring:
- Re-examine post-drainage symptom relief before disposition (Klug Dan Med J 2017)
- Airway re-check; return precautions for airway, re-accumulation, Lemierre

Follow-up plan: Smoking-cessation counselling (smoking is an independent PTA risk factor — Klug Dan Med J 2017); ENT follow-up; recurrence counselling. Interval/quinsy tonsillectomy candidacy if ≥1 prior PTA or recurrent tonsillitis meeting AAO-HNS modifying-factor criteria (AAO-HNS Tonsillectomy 2019; Rosi-Schumacher 2023 — quinsy and interval tonsillectomy equivalent outcomes). Counsel return precautions for re-accumulation, airway, and Lemierre.
- Close-out criterion: follow-up + tonsillectomy-candidacy decision + return precautions documented

Monitoring phase: Expect symptomatic improvement within 24-48 h of adequate drainage + antibiotics; persistent fever, trismus, or pain at 24-48 h → re-image for re-accumulation / parapharyngeal-retropharyngeal extension / wrong-spectrum, do not silently extend antibiotics. Watch for delayed Lemierre (rigors, pleuritic chest pain, neck-vein tenderness) and post-drainage bleeding (Chang Cochrane 2016 — post-I&D bleed ~3.6%).

Disposition

Current setting: ed — Resolve cellulitis-vs-abscess (POCUS/CT), screen + route the dangerous extensions, drain a confirmed abscess at the bedside, start anaerobe/GAS antibiotic + adjunct steroid, decide admit vs discharge (Kim Acad Emerg Med 2023; Chang Cochrane 2016; Hur Laryngoscope 2018)

Disposition criteria:
- Discharge: successful bedside drainage, tolerating PO + analgesia, no red flag, reliable follow-up → oral antibiotics + ENT review
- Admit: trismus precluding drainage, dehydration/can't tolerate PO, immunocompromise, airway/deep-space/sepsis flag, failed outpatient drainage
- Route OUT by engine_id if airway/deep-space/sepsis positive

Escalation triggers (move to higher acuity):
- Airway compromise → ent.epiglottitis.core.v1 + emergent airway (Klug Dan Med J 2017)
- Parapharyngeal/retropharyngeal/mediastinal extension → ent.retropharyngeal-abscess.core.v1 + thoracic if mediastinitis (Hu Medicina 2022)
- qSOFA ≥2 / hypotension → id.sepsis.core.v1 (SSC)
- Failed bedside drainage / trismus precluding access → OR drainage / quinsy tonsillectomy (Rosi-Schumacher 2023)

Earlier-Return Triggers

Return-precaution thresholds (watch for):
- [LIFE_THREATENING] Stridor, tripod posture, air hunger, severe drooling with cyanosis, or rapidly deteriorating airway with trismus + muffled voice (Klug Dan Med J 2017 — airway obstruction is a PTA complication)
- [LIFE_THREATENING] Very high / rapidly rising CRP (e.g. >190-340 mg/L), chest or back pain, dyspnoea, or anterior-visceral/retropharyngeal space involvement on CT (Hu Medicina 2022 — mortality up to 85% if untreated)
- [LIFE_THREATENING] Rigors, pleuritic chest pain, neck-vein tenderness, septic pulmonary emboli, or persistent bacteraemia after an oropharyngeal infection — Fusobacterium necrophorum internal-jugular thrombophlebitis (Wright South Med J 2012; Tiwari Cureus 2023)

Citations

- Cochrane needle-aspiration-vs-incision-and-drainage review (Chang et al, Cochrane Database Syst Rev 2016) + Kim et al ultrasound diagnostic-accuracy systematic review/meta-analysis (Acad Emerg Med 2023) + Hur et al adjunct-corticosteroid systematic review (Laryngoscope 2018) + AAO-HNS Clinical Practice Guideline: Tonsillectomy in Children — Update (Mitchell et al, 2019) + Klug Fusobacterium-microbiology body of work (Dan Med J 2017) + Wright/Tiwari Lemierre literature [PMID:28009937](https://pubmed.ncbi.nlm.nih.gov/28009937/)
- Cited evidence (PMID 36625850) [PMID:36625850](https://pubmed.ncbi.nlm.nih.gov/36625850/)
- Cited evidence (PMID 28561258) [PMID:28561258](https://pubmed.ncbi.nlm.nih.gov/28561258/)
- Cited evidence (PMID 30921525) [PMID:30921525](https://pubmed.ncbi.nlm.nih.gov/30921525/)
- Cited evidence (PMID 37352593) [PMID:37352593](https://pubmed.ncbi.nlm.nih.gov/37352593/)

Last reconciled with current guidelines: 2026-05-17.
References
  • Cochrane needle-aspiration-vs-incision-and-drainage review (Chang et al, Cochrane Database Syst Rev 2016) + Kim et al ultrasound diagnostic-accuracy systematic review/meta-analysis (Acad Emerg Med 2023) + Hur et al adjunct-corticosteroid systematic review (Laryngoscope 2018) + AAO-HNS Clinical Practice Guideline: Tonsillectomy in Children — Update (Mitchell et al, 2019) + Klug Fusobacterium-microbiology body of work (Dan Med J 2017) + Wright/Tiwari Lemierre literature — PMID:28009937
  • Cited evidence (PMID 36625850) — PMID:36625850
  • Cited evidence (PMID 28561258) — PMID:28561258
  • Cited evidence (PMID 30921525) — PMID:30921525
  • Cited evidence (PMID 37352593) — PMID:37352593